Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect.

× No keyword cloud information.

13 in total

Review 1. Graft versus leukemia.

Authors: A Butturini; R P Gale
Journal: Immunol Res Date: 1992 Impact factor: 2.829

Review 2. Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited.

Authors: Abhinav Deol; Lawrence G Lum
Journal: Cancer Treat Rev Date: 2010-04-09 Impact factor: 12.111

Review 3. Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer.

Authors: Nathan Singh; Junwei Shi; Carl H June; Marco Ruella
Journal: Curr Hematol Malig Rep Date: 2017-12 Impact factor: 3.952

Review 4. Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen.

Authors: Renier J Brentjens; Kevin J Curran
Journal: Hematology Am Soc Hematol Educ Program Date: 2012

5. Monitoring minimal residual disease in patients with MLL-AF6 fusion transcript-positive acute myeloid leukemia following allogeneic bone marrow transplantation.

Authors: Hiroshi Takatsuki; Yuji Yufu; Yoshimichi Tachikawa; Naokuni Uike
Journal: Int J Hematol Date: 2002-04 Impact factor: 2.490

6. Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation.

Authors: M R Bishop; R M Dean; S M Steinberg; J Odom; S Z Pavletic; C Chow; S Pittaluga; C Sportes; N M Hardy; J Gea-Banacloche; A Kolstad; R E Gress; D H Fowler
Journal: Ann Oncol Date: 2008-08-05 Impact factor: 32.976

Review 7. Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation.

Authors: Shimon Slavin
Journal: Int J Hematol Date: 2003-10 Impact factor: 2.490

8. Cellular therapy following allogeneic stem-cell transplantation.

Authors: Alison Rager; David L Porter
Journal: Ther Adv Hematol Date: 2011-12

Review 9. 60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy.

Authors: Nicoletta Cieri; Katie Maurer; Catherine J Wu
Journal: Cancer Res Date: 2021-06-09 Impact factor: 12.701

10. Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report.

Authors: Betty K Hamilton; Gregory Vereb; Edward A Copelan
Journal: J Med Case Rep Date: 2013-01-14